PharmaTimes spoke with Within3 CEO Lance Hill about pharma remote work and how the industry will navigate this important shift.
In early 2020, COVID-19 made the transition to digital and virtual collaboration more urgent. “As home working becomes a more popular option worldwide, companies may have to adjust to ensure they don’t miss out on any of the ‘spontaneous interactions’ that can happen at an office,” Hill told Pharma Times.
“This can be addressed by ensuring everyone has an equal voice and feels they can query or challenge everything. Meaning people can proactively reach out to someone to ask why we’re doing something or offer some feedback. Not only does this make people more involved in what we’re pushing to achieve as a company, but it also encourages more open discussions and innovation.”
Keeping important work moving forward was a critical focus in the early months of the pandemic, and companies that were already using tactics like virtual advisory boards and asynchronous collaboration were ahead of the curve. These organizations experience less disruption as restriction and lockdown measures were enacted globally. As more typical interaction methods resumed, companies saw they could use asynchronous engagement to augment in-person communication and better use their time.
Read the whole article in PharmaTimes.
